Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet
Authors not listed
University of Minnesota · 2023
Abstract
The long-term study objective is to develop optimized nutritional therapies for surgery and test them in clinical practice. This pilot study will test a microbiome-optimization diet in colorectal cancer surgery patients. The study hypothesizes that the Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet will provide participants with increased microbiota accessible carbohydrates (MACs) to support the microbiome and improve outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Anonymous. (2023). Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet. <em>University of Minnesota</em>. https://clinicaltrials.gov/study/NCT05658263
Vancouver
Anonymous. Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet. University of Minnesota. 2023.
BibTeX
@misc{anon2023Bacter,
title = {Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet},
author = {Anonymous},
journal = {University of Minnesota},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Providence Healthcare 2019
Open access · US-GOV
Mind and Body: A Clinical Trial Evaluation of a Smartphone App-based Mindfulness Intervention to Support Psychosocial Resilience in Aging Patients
Seoul National University Hospital 2015
Open access · US-GOV
Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand
Radboud University Medical Center 2018
Open access · US-GOV
Practice Variation in Colon Cancer Surgery Care in Older Patients
Instituto de Investigación Biomédica de Salamanca 2021
Open access · US-GOV
Lifestyles, Arterial Aging and Its Relationship With the Intestinal Microbiota (MIVAS III Study)
Novo Nordisk A/S 2023
Open access · US-GOV
A Randomised Double-blind Placebo-controlled Clinical Study Investigating the Effects of Semaglutide s.c. Once-weekly Versus Placebo on Central and Peripheral Inflammation in Participants With Alzheimer's Disease
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 2014
Open access · US-GOV